BioMarin Pharmaceutical (NASDAQ:BMRN) Earns “Sector Perform” Rating from Royal Bank of Canada
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report)‘s stock had its “sector perform” rating reissued by investment analysts at Royal Bank of Canada in a note issued to investors on Wednesday, Benzinga reports. They currently have a $80.00 target price on the biotechnology company’s stock. Royal Bank of Canada’s price objective indicates a potential upside of […]
More Stories
Why Businesses Choose Virtual Offices in NYC
Manhattan is one of the most expensive real estate markets in the world, and yet thousands of companies plant their...
What are the Three Goals of Cybersecurity? A Complete Guide on the CIA Triad
With the continuously moving environment, the need for cybersecurity has increased. Digital life is growing faster than ever. One weak...
Why Teens Are Struggling to Find Summer Jobs
By Troy Myers Joslyne Baird has been looking for a job for about a year to help her family pay...
Pentagon Awards Major Tomahawk Missile Contract
By Timothy Frudd The Department of War announced a major contract with a U.S. defense contractor on Aug. 17 to...
DOJ Opens Path to Restore Federal Gun Rights for 30 Million Americans
By Tom Gantert The Justice Department announced on Aug. 17 a new process that will allow eligible individuals prohibited from...
China Used Sex, Donations, Planted Interns to Influence US Political System: Declassified Docs
By Travis Gillmore WASHINGTON— Nearly 150 pages of newly declassified FBI documents paint the clearest picture yet of the relationship...